Healthcare Triangle, Inc.

Healthcare Triangle, Inc. reported a significant increase in net revenue for the first half of 2026, reaching $19.05 million, up 162% year-over-year. However, the company's net loss also widened substantially to $(10.62) million. The period saw the strategic acquisition of Teyame 360 S.L. and Datono Mediacion S.L., which significantly impacted the balance sheet, increasing total assets to $73.64 million. Despite negative operating cash flows, the company's liquidity concerns are mitigated by increased stockholders' equity and access to a $50 million Equity Line of Credit.

Healthcare Triangle, Inc. issued a total of 12,546,540 shares of common stock on July 28, 2026, related to the Teyame AI LLC acquisition and a Securities Exchange Agreement with SecureKloud Technologies Ltd. These issuances, approved by shareholders, increase the company's total outstanding shares to 14,644,322 and significantly enhance its compliance with Nasdaq's new $5 million Market Value of Listed Securities requirement, reaching approximately $23.87 million.

Healthcare Triangle, Inc. filed an S-1 registration statement for the resale of up to 28,000,000 shares of common stock by Hudson Global Ventures, LLC. These shares include 27,950,000 shares issued or issuable under an Equity Purchase Agreement dated June 12, 2026, and 50,000 shares from a warrant. The company will not receive proceeds from the resale by the Selling Stockholder, but may receive up to $50,000,000 in aggregate gross proceeds under the Equity Purchase Agreement.

Healthcare Triangle, Inc. announced its 2026 Annual Meeting of Stockholders to be held virtually on July 17, 2026. Shareholders will vote on several key proposals, including the election of four directors, ratification of the independent auditor, and an amendment to the 2020 Stock Incentive Plan for automatic share increases. Additionally, the company seeks approval for significant share issuances related to a settlement agreement, a share purchase agreement, and convertible debentures, as well as potential issuances exceeding Nasdaq's Exchange Cap.

Healthcare Triangle, Inc. entered into a Securities Exchange Agreement to issue 2,828,167 common shares to SecureKloud Technologies Ltd. as a make-whole for previously devalued Series B Preferred Stock, subject to stockholder approval. Concurrently, the company amended a Share Purchase Agreement for an acquisition, revising the purchase consideration to include $12 million in restricted common stock and 18,000 shares of preferred stock. The amendment also provides for a potential pre-funded warrant and 5,000 preferred shares for management earnouts, with all equity issuances subject to shareholder approval.

Healthcare Triangle, Inc. announced the closing of a private placement offering of $4.235 million in aggregate principal amount of 15% original issue discount senior convertible promissory notes, generating approximately $3.6 million in gross proceeds. The notes mature on December 12, 2026, and are convertible into common stock under certain conditions. Additionally, the company entered into an Equity Purchase Agreement with Hudson Global Ventures, LLC, allowing the company to sell up to $50 million of its common stock over a 36-month period, subject to various conditions and limitations. A warrant to purchase 50,000 shares was also issued.

Healthcare Triangle, Inc. completed the acquisition of Teyame 360 S.L. and Datono Mediacion S.L. on January 1, 2026, expanding its services into AI-powered omnichannel customer experience, marketing, and financial/insurance distribution. For the first quarter of 2026, the company reported a significant increase in net revenue to $9.86 million, up from $3.70 million in the prior year. However, the net loss also widened to $6.20 million, compared to a net loss of $1.70 million in Q1 2025, primarily due to increased operating expenses and a change in fair value.

Healthcare Triangle, Inc. has filed an amendment to its annual report on Form 10-K/A for the fiscal year ended December 31, 2025. The filing indicates the company's status as a non-accelerated filer, smaller reporting company, and emerging growth company. As of June 30, 2025, the aggregate market value of the registrant's common stock held by non-affiliates was approximately $40.6 million.

Healthcare Triangle, Inc. (HCTI) filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The company reported an aggregate market value of approximately $40,659,512 for common stock held by non-affiliates as of June 30, 2025. HCTI is classified as a non-accelerated filer, a smaller reporting company, and an emerging growth company.

Healthcare Triangle, Inc. (HCTI) entered into a Platform Development Agreement with SecureKloud Technologies Limited (SKL) and its subsidiary Blockedge Technologies Inc. The agreement, effective March 31, 2026, tasks SKL and Blockedge with designing and developing an integrated health advisory and care platform, including AI tools, for HCTI's commercial offerings. The project is expected to be completed within 12-15 months, by September 30, 2027, with all intellectual property rights exclusively assigned to Healthcare Triangle.